To explore whether Kremen2 inhibited the epithelial-mesenchymal transition (EMT) in NSCLC cells, we analyzed some EMT biomarkers by RT-qPCR after Kremen2 knockdown. The gene discussed is KREMEN2; the disease is non-small cell lung carcinoma.